Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older - Reply

Richard G. Bach, Christopher P. Cannon, Michael A. Blazing

Research output: Contribution to journal › Letter

Cite this

@article{9d440af3db2f40a097699f6b4529c341,

title = "Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older - Reply",

author = "Bach, {Richard G.} and Cannon, {Christopher P.} and Blazing, {Michael A.}",

year = "2020",

month = feb,

doi = "10.1001/jamacardio.2019.5241",

language = "English",

volume = "5",

pages = "235--236",

journal = "JAMA Cardiology",

issn = "2380-6583",

number = "2",

}

TY - JOUR

T1 - Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older - Reply

AU - Bach, Richard G.

AU - Cannon, Christopher P.

AU - Blazing, Michael A.

PY - 2020/2

Y1 - 2020/2

UR - http://www.scopus.com/inward/record.url?scp=85077580951&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2019.5241

DO - 10.1001/jamacardio.2019.5241

M3 - Letter

C2 - 31895449

AN - SCOPUS:85077580951

VL - 5

SP - 235

EP - 236

JO - JAMA Cardiology

JF - JAMA Cardiology

SN - 2380-6583

IS - 2

ER -